Rauwolscine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Rauwolscine
Rauwolscine.png
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
CAS Number
  • 131-03-3 ☒N 6211-32-1 (HCl)
PubChem CID
  • 643606
IUPHAR/BPS
  • 136
ChemSpider
  • 558737 ☑Y
ChEBI
  • CHEBI:48562 ☑Y
ChEMBL
  • CHEMBL10347 ☑Y
ECHA InfoCard 100.004.553
Chemical and physical data
Formula C21H26N2O3
Molar mass 354.44 g/mol
 ☒N☑Y (what is this?)   (verify)

Rauwolscine, also known as isoyohimbine, α-yohimbine, and corynanthidine, is an alkaloid found in various species within the genera Rauwolfia and Pausinystalia (formerly known as Corynanthe).[1] It is a stereoisomer of yohimbine.[1] Rauwolscine is a central nervous system stimulant, a local anesthetic and a vague aphrodisiac.[1]

Rauwolscine acts predominantly as a α2-adrenergic receptor antagonist.[2][3] It has also been shown to function as a 5-HT1A receptor partial agonist and 5-HT2A and 5-HT2B receptor antagonist.[4][5][6]

See also

References

  1. ^ a b c KOHLI JD, DE NN (June 1956). "Pharmacological action of rauwolscine". Nature. 177 (4521): 1182. doi:10.1038/1771182a0. PMID 13334509.
  2. ^ Perry BD, U'Prichard DC (December 1981). "[3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors". European Journal of Pharmacology. 76 (4): 461–4. doi:10.1016/0014-2999(81)90123-0. PMID 6276200.
  3. ^ Kou Qin; Pooja R. Sethi; Nevin A. Lambert (August 2008). "Abundance and stability of complexes containing inactive G protein-coupled receptors and G proteins". The FASEB Journal. 22 (8): 2920–2927. doi:10.1096/fj.08-105775. PMC 2493464. PMID 18434433.
  4. ^ Arthur JM, Casañas SJ, Raymond JR (June 1993). "Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors". Biochemical Pharmacology. 45 (11): 2337–41. doi:10.1016/0006-2952(93)90208-E. PMID 8517875.
  5. ^ Kaumann AJ (June 1983). "Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 323 (2): 149–54. doi:10.1007/BF00634263. PMID 6136920.
  6. ^ Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL (January 1998). "[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor". Naunyn-Schmiedeberg's Archives of Pharmacology. 357 (1): 17–24. doi:10.1007/PL00005133. PMID 9459568. Archived from the original on 2001-09-11.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Rauwolscine&oldid=835865812"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Rauwolscine
This page is based on the copyrighted Wikipedia article "Rauwolscine"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA